Bresotec Medical is a Canadian startup based in Toronto, Ontario, that focuses on developing and commercializing technologies for the diagnosis and treatment of sleep disorders. The company's first product, BresoDx®, is an innovative cordless, battery-operated device designed to aid in the diagnosis of sleep apnea, utilizing proprietary acoustic and movement recording technology. Notably, the underlying technology was developed by iDAPT Research at Toronto Rehabilitation Institute, renowned as a leading rehabilitation research center globally and fully affiliated with the University of Toronto.
Founded in 2012 by UHN and MaRS Innovation, Bresotec Medical has received support from a non-profit incubator representing 14 of Toronto's top universities, institutions, and research institutes, as well as the MaRS Discovery District. With a focus on the Health Care and Medical Devices industries, Bresotec Medical aims to revolutionize the way sleep disorders are diagnosed and treated, ultimately advancing health through innovative technology.
For more information, visit their website at www.bresotec.com.
There is no investment information
No recent news or press coverage available for Bresotec Medical.